
NYSE:G
This summary was created by AI, based on 3 opinions in the last 12 months.
Genpact Ltd (G-N) has shown a commendable growth trajectory, boasting a 13% earnings growth rate over the past 15 years. Currently, it trades at a price-to-earnings ratio of 9.7x and displays a free cash flow yield of 8.5%, indicating that it might still hold strong potential as a growth company within the banking and insurance sectors. Despite facing a 20% decline this year largely attributed to unwarranted fears surrounding artificial intelligence, experts like Michael O'Reilly suggest exercising caution by setting appropriate stop-loss orders. This stock has experienced stagnation recently, prompting recommendations to cover positions to maintain discipline in investment strategies. Overall, while the fundamentals appear robust, the recent volatility reflects market sentiment that may not align with Genpact's actual performance and potential.
Genpact Ltd is a American stock, trading under the symbol G (previously G-N on Stockchase) on the New York Stock Exchange (G). It is usually referred to as NYSE:G or G
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on G (previously G-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is PAST TOP PICK. Read the latest stock experts' ratings for Genpact Ltd.
Genpact Ltd was recommended as a Top Pick by Bill Carrigan on 2009-08-28. Read the latest stock experts ratings for Genpact Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Genpact Ltd.
Genpact Ltd is covered by Stockchase experts and is worth watching.
On 2026-08-07, Genpact Ltd (G) stock closed at a price of $34.29.